Veritas Asset Management LLP Catalent, Inc. Transaction History

Veritas Asset Management LLP

$11.7 Billion
Q2 2024

A detailed history of Veritas Asset Management LLP transactions in Catalent, Inc. stock. As of the latest transaction made, Veritas Asset Management LLP holds 4,395,354 shares of CTLT stock, worth $265 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares

4,395,354

Previous 6,025,413 27.05%

Holding current value

$265 Million

Previous $340 Million 27.34%

% of portfolio

2.11%

Previous 2.85%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$53.58 - $57.02 $87.3 Million - $92.9 Million	-1,630,059 Reduced 27.05%	4,395,354 $247 Million
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $18.8 Million - $26.5 Million	-442,576 Reduced 6.84%	6,025,413 $340 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $5.53 Million - $8 Million	-171,783 Reduced 2.59%	6,467,989 $291 Million
Q3 2023 Oct 20, 2023	BUY	$44.2 - $50.2 $293 Million - $333 Million	6,639,772 New	6,639,772 $302 Million
Q2 2023 Aug 08, 2023	SELL	$31.86 - $67.26 $3.21 Million - $6.78 Million	-100,749 Reduced 1.46%	6,784,366 $294 Million
Q1 2023 May 10, 2023	SELL	$45.44 - $74.26 $195 Million - $318 Million	-4,284,700 Reduced 38.36%	6,885,115 $452 Million
Q4 2022 Feb 07, 2023	BUY	$41.39 - $81.0 $174 Million - $341 Million	4,212,040 Added 60.54%	11,169,815 $503 Million
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $4.76 Million - $7.43 Million	65,734 Added 0.95%	6,957,775 $503 Million
Q2 2022 Aug 03, 2022	SELL	$87.2 - $114.05 $9.39 Million - $12.3 Million	-107,645 Reduced 1.54%	6,892,041 $739 Million
Q1 2022 May 06, 2022	BUY	$94.19 - $124.49 $87.5 Million - $116 Million	929,400 Added 15.31%	6,999,686 $776 Million
Q4 2021 Feb 08, 2022	BUY	$119.57 - $139.07 $164 Million - $191 Million	1,372,841 Added 29.23%	6,070,286 $777 Million
Q3 2021 Oct 29, 2021	SELL	$109.17 - $142.35 $64.8 Million - $84.5 Million	-593,908 Reduced 11.22%	4,697,445 $625 Million
Q2 2021 Jul 29, 2021	BUY	$100.34 - $115.69 $47.3 Million - $54.5 Million	470,900 Added 9.77%	5,291,353 $572 Million
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $1.41 Million - $1.74 Million	13,919 Added 0.29%	4,820,453 $508 Million
Q4 2020 Feb 11, 2021	BUY	$85.88 - $105.36 $10.9 Million - $13.4 Million	127,300 Added 2.72%	4,806,534 $500 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $340 Million - $433 Million	4,679,234 New	4,679,234 $401 Million

Others Institutions Holding CTLT

# of Institutions

489

Shares Held

165M

Call Options Held

364K

Put Options Held

837K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritas Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Veritas Asset Management LLP with notifications on news.

Account

Veritas Asset Management LLP Catalent, Inc. Transaction History